Cited by — Stratifying Cardiovascular Risk in Patients With
<scp>HCC</scp>
Receiving Atezolizumab/Bevacizumab: A Comparison of
<scp>ESC</scp>
and
<scp>CARDIOSOR</scp>
Scores | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Stratifying Cardiovascular Risk in Patients With
<scp>HCC</scp>
Receiving Atezolizumab/Bevacizumab: A Comparison of
<scp>ESC</scp>
and
<scp>CARDIOSOR</scp>
Scores.
No admitted local citation edges point to this work yet.
